Journals / Anestezi Dergisi / 2021 / Cilt: 29 - Sayı: 2

Effects of Granisetron on Spinal Anesthesia-Induced Hypotension

Granisetronun Spinal Anestezi Kaynaklı Hipotansiyona Etkisi

Pages
132–139
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Intravenous granisetron reduces hypotension after spinal anesthesia, but it has no significant effect on heart rate.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: It was aimed to evaluate the effect of intravenous (IV) granisetron used for nausea and vomiting prophylaxis on hypotension and bradycardia caused by spinal anesthesia.
📊
Key Findings & Data:Methods: 120 ASA 1-2 patients undergoing elective surgery under spinal anesthesia were randomly divided into Group G (Ganisetron; n=60) and Group P (Placebo; n=60) groups.
💡
Conclusion & Impact:Conclusion: Intravenous granisetron reduces hypotension after spinal anesthesia, but it has no significant effect on heart rate.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: It was aimed to evaluate the effect of intravenous (IV) granisetron used for nausea and vomiting prophylaxis on hypotension and bradycardia caused by spinal anesthesia. Methods: 120 ASA 1-2 patients undergoing elective surgery under spinal anesthesia were randomly divided into Group G (Ganisetron; n=60) and Group P (Placebo; n=60) groups. Five minutes before spinal anesthesia, Group G received 1 mg intravenous granisetron diluted in 10 mL of isotonic sodium chloride solution and Group P received 10 mL of isotonic sodium chloride solution. Spinal anesthesia with hyperbaric bupivacaine 0.5%, 15 mg at the level of L4-5 was applied for both groups. Hemodynamic data, sensory and motor block parameters were recorded before and after spinal anaesthesia every 5 minutes during 20 minutes of surgery. Results: There was no difference in the demographic data of both groups. Although hemodynamic data showed a decrease in both groups according to initial values, blood pressure measurements in group G were significantly higher than the first measure values. There was no significant difference in heart rate values between the groups. Conclusion: Intravenous granisetron reduces hypotension after spinal anesthesia, but it has no significant effect on heart rate.

Özet

Amaç: Bulantı kusma profilaksisi için kullanılan intravenöz granisetronun spinal anestezi kaynak- lı hipotansiyon ve bradikardi üzerine etkisinin değerlendirilmesi amaçlandı. Yöntem: Spinal anestezi altında elektif opere edilen, ASA 1-2 sınıfında olan 120 hasta rastgele olarak Grup G (Granisetron; n=60) ve Grup P (Plasebo; n=60) gruplarına ayrıldı. Spinal anestezi- den 5 dk önce, G grubuna 10 mL %0.9 serum fizyolojikle seyreltilmiş 1 mg intravenöz granisetron ve P grubuna ise 10 mL intravenöz %0.9 serum fizyolojik uygulandı. İki gruptaki tüm hastalara 15 mg hiperbarik bupivakain %0.5 ile L4-5 seviyesinden spinal anestezi yapıldı. Motor blok derecesi ve seviyesi, sensoryal blok seviyesi ve hemodinamik veriler, anesteziden önce bir kez ve sonra ise 20 dk boyunca her 5 dk’da bir kaydedildi. Bulgular: Her iki grubun demografik verilerinde anlamlı fark yoktu. İlk değerlere göre hemodina- mik verilerde her iki grupta da düşme görülse de G grubunda sistolik, diastolik ve ortalama kan basıncı ölçümleri istatistiksel olarak anlamlı derecede daha yüksekti. Kalp atım hızında anlamlı fark gözlenmedi. Sonuç: İntravenöz olarak uygulanan granisetron spinal anestezi sonrası gelişen hipotansiyonu azaltır, ancak kalp atım hızı üzerine belirgin etkisi yoktur.

🔖

Cite This Article

Dönmez, A., Sayın, M., Çataroğlu, C. K., Alptekin, A., Gezer, A. (2022). Effects of Granisetron on Spinal Anesthesia-Induced Hypotension. Anestezi Dergisi, Cilt: 29 - Sayı: 2, 132–139. https://ajindex.com/articles/440456

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Campagna JA, Carter C. Clinical relevance of the Bezold-Jarisch reflex. Anesthesiology. 2003;98:1250- 60.
  2. Tuncer Uzun S, Reisli R, Santral Sinir Blokları, Güldoğuş F, Gürkan Y, Rejyonal Anestezi. İstanbul, NobelTıp Kitabevleri, 2013;93-120
  3. Liu SS, McDonald SB. Current issues in spinal anesthe- sia. Anesthesiology. 2001;94:888-906.
  4. Carpenter RL, Caplan RA, Brown DL, Stephenson C, Wu R. Incidence and risk factors for side effects of spinal anesthesia. Anesthesiology. 1992;76:906-16.
  5. Morgan GE, Mikhail MS, Butterworth JF, Mackey DC, Wasnick JD. Klinik Anesteziyoloji (LANGE), Beşinci Baskı, Ankara, Güneş Kitabevi. 2015. s.937-75
  6. Kayhan Z. Klinik Anestezi, Santral Bloklar Spinal ve Epidural Anestezi. İstanbul: Logos Yayıncılık 2004: 570- 86
  7. Martinek RM. Witnessed asystole during spinal anest- hesia treated with atropine and ondansetron: a case report. Can J Anesthesia. 2004;51:226-30.
  8. Veelken R, Sawin LL, DiBona GF. Epicardial serotonin receptors in circulatory control in conscious Sprague- Dawley rats. Am J Physiol. 1990;258:H466-H72.
  9. Veelken R, Hilgers KF, Leonard M, et al. A highly selec- tive cardiorenal serotonergic 5-HT3-mediated reflex in rats. Am J Physiol. 1993;264:H1871-H7.
  10. White CM, Chow MS, Fan C, Kluger J, Bazunga M. Efficacy of Intravenous Granisetron in Suppressing the Bradycardia and Hypotension Associated with a Rabbit Model of the Bezold-Jarisch Reflex. J Clin Pharmacol. 1998;38:172-7.
  11. Owczuk R, Wenski W, Polak-Krzeminska A, Twardowski P, Arszulowicz R, Dylczyk-Sommer A, et al. Ondansetron given intravenously attenuates arterial blood pressure drop due to spinal anesthesia: adouble-blind, placebo- controlledstudy. Reg Anesth Pain Med. 2008;33:332-9
  12. Kelsaka E, Baris S, Karakaya D, Sarihasan B. Comparison of ondansetron and meperidine for prevention of shi- vering in patients undergoing spinal anesthesia. Reg Anesth Pain Med. 2006;31:40-5.
  13. Sahoo T, SenDasgupta C, Goswami A, Hazra A. Reduction in spinal-induced hypotension with ondan- setron in parturients undergoing caesarean section: a double-blind randomised, placebo-controlled stu